| Literature DB >> 33640383 |
Sanchita Rauth1, Saswati Karmakar1, Surinder K Batra2, Moorthy P Ponnusamy3.
Abstract
An improved understanding of stem cell niches, organogenesis, and disease models has paved the way for developing a three-dimensional (3D) organoid culture system. Organoid cultures can be derived from primary tissues (single cells or tissue subunits), adult stem cells (ASCs), induced pluripotent stem cells (iPSCs), or embryonic stem cells (ESCs). As a significant technological breakthrough, 3D organoid models offer a promising approach for understanding the complexities of human diseases ranging from the mechanistic investigation of disease pathogenesis to therapy. Here, we discuss the recent applications, advantages, and limitations of organoids as in vitro models for studying metabolomics, drug development, infectious diseases, and the gut microbiome. We further discuss the use of organoids in cancer modeling using high throughput sequencing approaches. Published by Elsevier B.V.Entities:
Keywords: Disease modeling; Gut MIcrobiota; Metabolism; Organoids; Tumor microenvironment
Mesh:
Year: 2021 PMID: 33640383 PMCID: PMC8068668 DOI: 10.1016/j.bbcan.2021.188527
Source DB: PubMed Journal: Biochim Biophys Acta Rev Cancer ISSN: 0304-419X Impact factor: 10.680